Psychotherapy + TRYP-0082 for irritable bowel syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Jan 2024: Trial registered, NCT06206265
  2. 17 Jan 2024: Trial started, NCT06206265

The trials

NCT06206265: Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

State
Under way
Phase
Phase 2
People
14 taking part
Started
17 Jan 2024
Primary completion
1 Mar 2026
Arms
Open Label Oral Psilocybin
Results
None posted
  1. 16 Jan 2024: Trial registered
  2. 17 Jan 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.